The Fellowship of Privileged Scaffolds-One Structure to Inhibit Them All

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2021 Nov 27

PMID 34832946

Citations 6

Authors

Marcin Skorenski

Marcin Sienczyk

Affiliations

Soon will be listed here.

Abstract

Over the past few years, the application of privileged structure has emerged as a powerful approach to the discovery of new biologically active molecules. Privileged structures are molecular scaffolds with binding properties to the range of different biological targets. Moreover, privileged structures typically exhibit good drug-like properties, thus assuring more drug-like properties of modified compound. Our main objective is to discuss the privileged structures used for the development of antiviral agents.

Citing Articles

Synthesis and in vitro antitrypanosomatid activity of novel 5-nitroindole-rhodanine conjugates.

Badenhorst E, Aucamp J, Kannigadu C, Janse van Rensburg H, Suganuma K, NDa D Future Med Chem. 2025; 17(5):557-573.

PMID: 39995114 PMC: 11901381. DOI: 10.1080/17568919.2025.2470110.

You Win Some, You Lose Some: Modifying the Molecular Periphery of Nitrofuran-Tagged Diazaspirooctane Reshapes Its Antibacterial Activity Profile.

Vinogradova L, Komarova K, Lukin A, Zhuravlev M, Deniskin D, Poliakova A Int J Mol Sci. 2025; 26(1.

PMID: 39796065 PMC: 11720470. DOI: 10.3390/ijms26010207.

The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles.

Boshoff H, Malhotra N, Barry 3rd C, Oh S Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399426 PMC: 10892018. DOI: 10.3390/ph17020211.

Urea Hydrogen Peroxide and Ethyl Lactate, an Eco-Friendly Combo System in the Direct C(sp)-H Bond Selenylation of Imidazo[2,1-]thiazole and Related Structures.

Moraes C, Santos R, Cavalcante M, Guilhermi J, Ali M, Botteselle G ACS Omega. 2023; 8(42):39535-39545.

PMID: 37901565 PMC: 10600889. DOI: 10.1021/acsomega.3c05338.

The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies.

Nitulescu G, Stancov G, Seremet O, Nitulescu G, Mihai D, Duta-Bratu C Molecules. 2023; 28(14).

PMID: 37513232 PMC: 10385367. DOI: 10.3390/molecules28145359.

References

Sun L, Zhu L, Qian K, Qin B, Huang L, Chen C . Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. J Med Chem. 2012; 55(16):7219-29. PMC: 3462592. DOI: 10.1021/jm3007678. View

Alagarsamy V, Chitra K, Saravanan G, Solomon V, Sulthana M, Narendhar B . An overview of quinazolines: Pharmacological significance and recent developments. Eur J Med Chem. 2018; 151:628-685. DOI: 10.1016/j.ejmech.2018.03.076. View

Kim J, Jung Y, Kim C, Shin J, Scheers E, Lee J . A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication. J Med Chem. 2017; 60(13):5472-5492. DOI: 10.1021/acs.jmedchem.7b00175. View

Dorababu A . Indole - a promising pharmacophore in recent antiviral drug discovery. RSC Med Chem. 2021; 11(12):1335-1353. PMC: 8126882. DOI: 10.1039/d0md00288g. View

Leneva I, Russell R, Boriskin Y, Hay A . Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res. 2008; 81(2):132-40. DOI: 10.1016/j.antiviral.2008.10.009. View

Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-90. DOI: 10.1056/NEJMoa0708857. View

Wang Z, Bennett E, Wilson D, Salomon C, Vince R . Rationally designed dual inhibitors of HIV reverse transcriptase and integrase. J Med Chem. 2007; 50(15):3416-9. DOI: 10.1021/jm070512p. View

Vigant F, Lee J, Hollmann A, Tanner L, Ataman Z, Yun T . A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion. PLoS Pathog. 2013; 9(4):e1003297. PMC: 3630091. DOI: 10.1371/journal.ppat.1003297. View

Baell J, Holloway G . New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010; 53(7):2719-40. DOI: 10.1021/jm901137j. View

10.

Massari S, Daelemans D, Letizia Barreca M, Knezevich A, Sabatini S, Cecchetti V . A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. J Med Chem. 2009; 53(2):641-8. DOI: 10.1021/jm901211d. View

11.

Morphy R, Rankovic Z . Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005; 48(21):6523-43. DOI: 10.1021/jm058225d. View

12.

Reiter C, Frohlich T, Gruber L, Hutterer C, Marschall M, Voigtlander C . Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. Bioorg Med Chem. 2015; 23(17):5452-8. DOI: 10.1016/j.bmc.2015.07.048. View

13.

Xu L, Liu H, Hong A, Vivian R, Murray B, Callebaut C . Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350). Bioorg Med Chem Lett. 2014; 24(3):995-9. DOI: 10.1016/j.bmcl.2013.12.057. View

14.

Zhan P, Liu X . Designed multiple ligands: an emerging anti-HIV drug discovery paradigm. Curr Pharm Des. 2009; 15(16):1893-917. DOI: 10.2174/138161209788453266. View

15.

Efferth T, Marschall M, Wang X, Huong S, Hauber I, Olbrich A . Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J Mol Med (Berl). 2002; 80(4):233-42. DOI: 10.1007/s00109-001-0300-8. View

16.

Liu S, Wang W, Jiang L, Wan S, Zhang L, Yu R . 2-Pyridinyl-4(3H)-quinazolinone: a scaffold for anti-influenza A virus compounds. Chem Biol Drug Des. 2015; 86(5):1221-5. DOI: 10.1111/cbdd.12589. View

17.

He R, Forman M, Mott B, Venkatadri R, Posner G, Arav-Boger R . Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety. Antimicrob Agents Chemother. 2013; 57(9):4208-14. PMC: 3754318. DOI: 10.1128/AAC.00893-13. View

18.

Stammers T, Coulombe R, Duplessis M, Fazal G, Gagnon A, Garneau M . Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay. Bioorg Med Chem Lett. 2013; 23(24):6879-85. DOI: 10.1016/j.bmcl.2013.09.102. View

19.

Dou D, Mandadapu S, Alliston K, Kim Y, Chang K, Groutas W . Design and synthesis of inhibitors of noroviruses by scaffold hopping. Bioorg Med Chem. 2011; 19(19):5749-55. PMC: 3199213. DOI: 10.1016/j.bmc.2011.08.032. View

20.

Sancineto L, Iraci N, Letizia Barreca M, Massari S, Manfroni G, Corazza G . Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands. Bioorg Med Chem. 2014; 22(17):4658-66. DOI: 10.1016/j.bmc.2014.07.018. View